Published in J Urol on October 01, 2003
Increased prevalence of testicular microlithiasis in men with familial testicular cancer and their relatives. Br J Cancer (2008) 1.05
Evidence-based pragmatic guidelines for the follow-up of testicular cancer: optimising the detection of relapse. Br J Cancer (2008) 1.01
Intratubular germ cell neoplasms of the testis and bilateral testicular tumors: clinical significance and management options. Indian J Urol (2010) 0.81
Surveillance of testicular microlithiasis? Results of an UK based national questionnaire survey. BMC Urol (2006) 0.78
Microinvasive germ cell tumor of the testis. Virchows Arch (2005) 0.77
Prevalence of small testicular hyperechogenic foci in subgroups of 382 non-vasectomized, azoospermic men: a retrospective cohort study. Andrology (2017) 0.75
Editorial: testicular malignancies--high chance of cure-continuing opportunities to refine treatment. J Urol (2003) 0.75
Evaluation of testicular tumour calcification with digital orchiography. Eur Radiol (2013) 0.75
The timing of normal puberty and the age limits of sexual precocity: variations around the world, secular trends, and changes after migration. Endocr Rev (2003) 4.88
Human breast milk contamination with phthalates and alterations of endogenous reproductive hormones in infants three months of age. Environ Health Perspect (2006) 2.73
Body mass index in relation to semen quality and reproductive hormones among 1,558 Danish men. Fertil Steril (2004) 2.40
Public health implications of altered puberty timing. Pediatrics (2008) 2.26
ATM activation in normal human tissues and testicular cancer. Cell Cycle (2005) 2.25
European consensus conference on diagnosis and treatment of germ cell cancer: a report of the second meeting of the European Germ Cell Cancer Consensus group (EGCCCG): part I. Eur Urol (2007) 2.21
Recent decline in age at breast development: the Copenhagen Puberty Study. Pediatrics (2009) 2.09
Cryptorchidism and hypospadias as a sign of testicular dysgenesis syndrome (TDS): environmental connection. Birth Defects Res A Clin Mol Teratol (2010) 2.04
Vitamin D receptor and vitamin D metabolizing enzymes are expressed in the human male reproductive tract. Hum Reprod (2010) 2.00
Intrauterine exposure to mild analgesics is a risk factor for development of male reproductive disorders in human and rat. Hum Reprod (2010) 1.97
Testicular dysgenesis syndrome: mechanistic insights and potential new downstream effects. Fertil Steril (2008) 1.96
East-West gradient in semen quality in the Nordic-Baltic area: a study of men from the general population in Denmark, Norway, Estonia and Finland. Hum Reprod (2002) 1.91
Do perfluoroalkyl compounds impair human semen quality? Environ Health Perspect (2009) 1.81
Gene polymorphisms and male infertility--a meta-analysis and literature review. Reprod Biomed Online (2007) 1.79
Environmental chemicals and thyroid function. Eur J Endocrinol (2006) 1.75
Systemic absorption of the sunscreens benzophenone-3, octyl-methoxycinnamate, and 3-(4-methyl-benzylidene) camphor after whole-body topical application and reproductive hormone levels in humans. J Invest Dermatol (2004) 1.73
Activating mutations in FGFR3 and HRAS reveal a shared genetic origin for congenital disorders and testicular tumors. Nat Genet (2009) 1.72
Metabolism of phthalates in humans. Mol Nutr Food Res (2007) 1.70
Caffeine intake and semen quality in a population of 2,554 young Danish men. Am J Epidemiol (2010) 1.69
Estimating burden and disease costs of exposure to endocrine-disrupting chemicals in the European union. J Clin Endocrinol Metab (2015) 1.64
Larger testes and higher inhibin B levels in Finnish than in Danish newborn boys. J Clin Endocrinol Metab (2006) 1.63
Prenatal and adult exposures to smoking are associated with adverse effects on reproductive hormones, semen quality, final height and body mass index. Hum Reprod (2011) 1.60
OCT2, SSX and SAGE1 reveal the phenotypic heterogeneity of spermatocytic seminoma reflecting distinct subpopulations of spermatogonia. J Pathol (2011) 1.59
Urinary excretion of phthalates and paraben after repeated whole-body topical application in humans. Int J Androl (2008) 1.58
Embryonic stem cell-like features of testicular carcinoma in situ revealed by genome-wide gene expression profiling. Cancer Res (2004) 1.56
Dysregulation of the mitosis-meiosis switch in testicular carcinoma in situ. J Pathol (2013) 1.56
Environmental factors and puberty timing: expert panel research needs. Pediatrics (2008) 1.54
Is human fecundity declining? Int J Androl (2006) 1.52
From embryonic stem cells to testicular germ cell cancer-- should we be concerned? Int J Androl (2006) 1.48
Phenotypic characterisation of immune cell infiltrates in testicular germ cell neoplasia. J Reprod Immunol (2013) 1.41
Association of in utero exposure to maternal smoking with reduced semen quality and testis size in adulthood: a cross-sectional study of 1,770 young men from the general population in five European countries. Am J Epidemiol (2004) 1.38
European consensus conference on diagnosis and treatment of germ cell cancer: a report of the second meeting of the European Germ Cell Cancer Consensus Group (EGCCCG): part II. Eur Urol (2007) 1.37
Analysis of gene expression profiles of microdissected cell populations indicates that testicular carcinoma in situ is an arrested gonocyte. Cancer Res (2009) 1.35
Developmental expression of POU5F1 (OCT-3/4) in normal and dysgenetic human gonads. Hum Reprod (2004) 1.34
Role of environmental factors in the timing of puberty. Pediatrics (2008) 1.33
Persistent pesticides in human breast milk and cryptorchidism. Environ Health Perspect (2006) 1.33
Effects of ejaculatory frequency and season on variations in semen quality. Fertil Steril (2004) 1.32
Cryptorchidism: classification, prevalence and long-term consequences. Acta Paediatr (2007) 1.31
Increased number of sex chromosomes affects height in a nonlinear fashion: a study of 305 patients with sex chromosome aneuploidy. Am J Med Genet A (2010) 1.31
The impact of endocrine disruption: a consensus statement on the state of the science. Environ Health Perspect (2013) 1.28
Secular decline in male testosterone and sex hormone binding globulin serum levels in Danish population surveys. J Clin Endocrinol Metab (2007) 1.28
Mild gestational diabetes as a risk factor for congenital cryptorchidism. J Clin Endocrinol Metab (2006) 1.27
Transcription factor AP-2gamma is a developmentally regulated marker of testicular carcinoma in situ and germ cell tumors. Clin Cancer Res (2004) 1.27
Sex differences in the vaccine-specific and non-targeted effects of vaccines. Vaccine (2011) 1.27
Postnatal penile length and growth rate correlate to serum testosterone levels: a longitudinal study of 1962 normal boys. Eur J Endocrinol (2006) 1.26
Coordinated European investigations of semen quality: results from studies of Scandinavian young men is a matter of concern. Int J Androl (2006) 1.26
The emerging phenotype of the testicular carcinoma in situ germ cell. APMIS (2003) 1.24
Semen quality in sub-fertile range for a significant proportion of young men from the general German population: a co-ordinated, controlled study of 791 men from Hamburg and Leipzig. Int J Androl (2008) 1.23
Serum inhibin B and follicle-stimulating hormone levels as tools in the evaluation of infertile men: significance of adequate reference values from proven fertile men. J Clin Endocrinol Metab (2004) 1.23
Declining trends in conception rates in recent birth cohorts of native Danish women: a possible role of deteriorating male reproductive health. Int J Androl (2007) 1.22
Klinefelter syndrome: expanding the phenotype and identifying new research directions. Genet Med (2003) 1.21
Assessment of circulating sex steroid levels in prepubertal and pubertal boys and girls by a novel ultrasensitive gas chromatography-tandem mass spectrometry method. J Clin Endocrinol Metab (2009) 1.21
Meaningful peer review is integral to quality science and should provide benefits to the authors and reviewers alike. Andrology (2013) 1.18
The relationship between anogenital distance and reproductive hormone levels in adult men. J Urol (2011) 1.16
Testicular dysgenesis syndrome: possible role of endocrine disrupters. Best Pract Res Clin Endocrinol Metab (2006) 1.16
Cryptorchidism and maternal alcohol consumption during pregnancy. Environ Health Perspect (2006) 1.14
Regional differences in semen qualities in the Baltic region. Int J Androl (2002) 1.14
Presumed pluripotency markers UTF-1 and REX-1 are expressed in human adult testes and germ cell neoplasms. Hum Reprod (2008) 1.13
The early human germ cell lineage does not express SOX2 during in vivo development or upon in vitro culture. Biol Reprod (2008) 1.13
Dual effects of phytoestrogens result in u-shaped dose-response curves. Environ Health Perspect (2002) 1.12
Origin of pluripotent germ cell tumours: the role of microenvironment during embryonic development. Mol Cell Endocrinol (2008) 1.11
Prevalence and incidence of precocious pubertal development in Denmark: an epidemiologic study based on national registries. Pediatrics (2005) 1.09
Analysis of cell-type-specific gene expression during mouse spermatogenesis. Biol Reprod (2004) 1.09
Abnormal sex chromosome constitution and longitudinal growth: serum levels of insulin-like growth factor (IGF)-I, IGF binding protein-3, luteinizing hormone, and testosterone in 109 males with 47,XXY, 47,XYY, or sex-determining region of the Y chromosome (SRY)-positive 46,XX karyotypes. J Clin Endocrinol Metab (2007) 1.09
Association between testicular dysgenesis syndrome (TDS) and testicular neoplasia: evidence from 20 adult patients with signs of maldevelopment of the testis. APMIS (2003) 1.08
Systemic uptake of diethyl phthalate, dibutyl phthalate, and butyl paraben following whole-body topical application and reproductive and thyroid hormone levels in humans. Environ Sci Technol (2007) 1.08
From gonocytes to testicular cancer: the role of impaired gonadal development. Ann N Y Acad Sci (2007) 1.08
Longitudinal changes in semen parameters in young Danish men from the Copenhagen area. Hum Reprod (2005) 1.08
A path forward in the debate over health impacts of endocrine disrupting chemicals. Environ Health (2014) 1.08
Frequent polymorphism of the mitochondrial DNA polymerase gamma gene (POLG) in patients with normal spermiograms and unexplained subfertility. Hum Reprod (2004) 1.08
Genital anomalies in boys and the environment. Best Pract Res Clin Endocrinol Metab (2010) 1.08
Identity of M2A (D2-40) antigen and gp36 (Aggrus, T1A-2, podoplanin) in human developing testis, testicular carcinoma in situ and germ-cell tumours. Virchows Arch (2006) 1.07
Nuclear transit of human zipcode-binding protein IMP1. Biochem J (2003) 1.07
Development and descent of the testis in relation to cryptorchidism. Acta Paediatr (2007) 1.06
Leydig cell micronodules are a common finding in testicular biopsies from men with impaired spermatogenesis and are associated with decreased testosterone/LH ratio. J Pathol (2003) 1.05
Age at voice break in Danish boys: effects of pre-pubertal body mass index and secular trend. Int J Androl (2007) 1.04
Spermaturia and serum hormone concentrations at the age of puberty in boys prenatally exposed to polychlorinated biphenyls. Eur J Endocrinol (2002) 1.02
The cancer-testis gene, NY-ESO-1, is expressed in normal fetal and adult testes and in spermatocytic seminomas and testicular carcinoma in situ. Lab Invest (2002) 1.02
Hormonal changes in 3-month-old cryptorchid boys. J Clin Endocrinol Metab (2006) 1.01
Putative effects of endocrine disrupters on pubertal development in the human. Best Pract Res Clin Endocrinol Metab (2002) 1.01
Impaired reproductive development in sons of women occupationally exposed to pesticides during pregnancy. Environ Health Perspect (2008) 1.01
Environment, testicular dysgenesis and carcinoma in situ testis. Best Pract Res Clin Endocrinol Metab (2007) 1.00